摘要
目的:探讨瞬时弹性成像系统(Fibroscan)在非酒精性脂肪性肝病(NAFLD)中的诊断价值及其与中医分型的关系。方法:选择通过CT确诊的NAFLD的患者共64例,另外设健康对照50例,采用Fibroscan、CT肝/脾比值进行诊断比较,探讨Fibroscan在非酒精性脂肪性肝病中的诊断价值及其与中医分型的关系。结果:Fibroscan在诊断获得了最高的诊断效能,其灵敏度81.25%、特异性85.29%、阳性预测值91.22%、阴性预测值70.73%、约登指数0.66、ROC曲线下面积为0.78,并证明中医虚证患者Fibroscan的检测值大于实证患者[(269.32±33.98)vs(228.44±31.05),t=4.093,P=0.031]。结论:Fibroscan在NAFLD中的诊断效能较好,是定量诊断脂肪肝的可靠技术,与目前公认的CT诊断技术具有可比性,且中医虚实证型的Fibroscan检测值差异有显著性意义。
Objective:To investigate the diagnostic value of fibroscan in nonalcoholic fatty liver disease and relationship with TCM differentiation.Methods:sixty four cases with nonalcoholic fatty liver disease diagnosed by CT and 50 cases of healthy volunteers,as the control group were all selected.Fibroscan,CT and liver/spleen ratio were used for diagnosis and comparison.Results;FibroScan has the highest diagnostic efficiency in the diagnosis,the sensitivity was 81.25%,specificity 85.29%,positive predictive value 91.22%,negative predictive value 70.73%,Youden index 0.66 and the area under the ROC curve was 0.78.At the same time,the detection value of Fibroscan in patients with deficiency syndrome is greater than excess syndrome(269.32 ±33.98 vs 228.44 ±31.05,t = 4.093,P =0.031) Conclusion.- Fibroscan had better diagnostic efficiency in NAFLD than CT,which provides new ideas for clinical diagnosis on NAFLD.
出处
《中西医结合肝病杂志》
CAS
2016年第2期79-80,114,共3页
Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases